During these live, interactive, educational forums, you can engage with world-renowned medical experts and other clinicians as they present research and case studies on current sarcoidosis topics.
We are pleased to offer these programs to all attendees at no charge.
Join FSR on March 28, 2024 at 4pm CST for our next FSR Clinical Education & Engagement Series Event on Neurosarcoidosis
Join our expert panel as we discuss Neurosarcoidosis. Enhance your understanding and hear from the best in the field as we explore the latest advancements in treatment and research.
Learning Objectives:
-Describe the clinical spectrum neurosarcoidosis
-Explain symptoms of on-neurologic sarcoidosis related symptoms
-Summarize the symptoms, diagnosis, and treatment for peripheral nervous system in sarcoidosis
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and the Foundation for Sarcoidosis Research. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this live activity for a maximum of 2.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Section # 2445
Keynote Speaker:
Dr. David Clifford
Professor of Neurology, Professor of Medicine, Washington University School of Medicine+ in St. Louis
Dr. Carlos Pardo
Professor of Neurology, Johns Hopkins University
Dr. Jinny Tavee
Chief of the Division of Neurology & Behavioral Health, National Jewish Health
Nov 9, 2023: Advancing Sarcoidosis Clinical Trials & Research
June 8, 2023: The Heart of Sarcoidosis
March 24, 2023: Visions for Progress in Sarcoidosis in 10 Years
October 27, 2022: Pulmonary Sarcoidosis
June 15, 2022: COVID and Sarcoidosis
Sponsored by Mallinckrodt Pharmaceuticals and Boehringer Ingelheim
